Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiosurgery | 8 | 2025 | 148 | 1.740 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 2 | 2025 | 107 | 1.660 |
Why?
|
| Brain Neoplasms | 7 | 2026 | 1305 | 1.090 |
Why?
|
| Organs at Risk | 1 | 2025 | 48 | 0.900 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2025 | 101 | 0.860 |
Why?
|
| Quality Assurance, Health Care | 1 | 2024 | 205 | 0.750 |
Why?
|
| Brachytherapy | 2 | 2019 | 85 | 0.640 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2019 | 16 | 0.580 |
Why?
|
| Lung Neoplasms | 7 | 2022 | 1547 | 0.570 |
Why?
|
| Radiotherapy Dosage | 3 | 2025 | 217 | 0.560 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2026 | 587 | 0.550 |
Why?
|
| Artificial Intelligence | 2 | 2026 | 349 | 0.340 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 1406 | 0.330 |
Why?
|
| Small Cell Lung Carcinoma | 2 | 2020 | 33 | 0.320 |
Why?
|
| Intracranial Arteriovenous Malformations | 2 | 2020 | 36 | 0.310 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2019 | 1263 | 0.310 |
Why?
|
| Mastectomy | 2 | 2020 | 74 | 0.310 |
Why?
|
| Arteriovenous Fistula | 2 | 2020 | 54 | 0.300 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2022 | 356 | 0.260 |
Why?
|
| Pituitary Neoplasms | 2 | 2017 | 74 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2026 | 3742 | 0.240 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2020 | 155 | 0.230 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2021 | 747 | 0.220 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2026 | 229 | 0.210 |
Why?
|
| Retrospective Studies | 14 | 2025 | 17577 | 0.200 |
Why?
|
| Regression Analysis | 1 | 2025 | 760 | 0.200 |
Why?
|
| Hippocampus | 2 | 2024 | 794 | 0.170 |
Why?
|
| Computer Simulation | 1 | 2024 | 670 | 0.170 |
Why?
|
| Treatment Outcome | 7 | 2024 | 12824 | 0.170 |
Why?
|
| Radiation Oncology | 1 | 2020 | 29 | 0.160 |
Why?
|
| Cranial Irradiation | 1 | 2020 | 71 | 0.150 |
Why?
|
| Humans | 23 | 2026 | 130204 | 0.150 |
Why?
|
| Mastectomy, Segmental | 1 | 2019 | 37 | 0.150 |
Why?
|
| Rhabdoid Tumor | 1 | 2019 | 46 | 0.150 |
Why?
|
| Kallikreins | 1 | 2019 | 26 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2024 | 2057 | 0.150 |
Why?
|
| Pneumonectomy | 1 | 2020 | 154 | 0.140 |
Why?
|
| Mesothelioma | 1 | 2020 | 96 | 0.140 |
Why?
|
| Teratoma | 1 | 2019 | 120 | 0.140 |
Why?
|
| Prostate-Specific Antigen | 1 | 2019 | 222 | 0.140 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 272 | 0.140 |
Why?
|
| Sphenoid Sinus | 1 | 2017 | 9 | 0.130 |
Why?
|
| Organ Size | 1 | 2019 | 408 | 0.130 |
Why?
|
| Corticotrophs | 1 | 2017 | 1 | 0.130 |
Why?
|
| Treatment Failure | 1 | 2019 | 345 | 0.130 |
Why?
|
| Prospective Studies | 4 | 2024 | 6407 | 0.130 |
Why?
|
| Early Medical Intervention | 1 | 2017 | 32 | 0.130 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 2591 | 0.130 |
Why?
|
| Neoplasm Staging | 4 | 2022 | 1278 | 0.130 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 205 | 0.130 |
Why?
|
| Neoplasm, Residual | 1 | 2017 | 132 | 0.130 |
Why?
|
| Risk | 1 | 2019 | 724 | 0.130 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 902 | 0.120 |
Why?
|
| Prostate | 1 | 2019 | 402 | 0.120 |
Why?
|
| Adenoma | 1 | 2017 | 142 | 0.120 |
Why?
|
| Aged | 8 | 2024 | 20818 | 0.120 |
Why?
|
| Time-to-Treatment | 1 | 2017 | 209 | 0.110 |
Why?
|
| Middle Aged | 8 | 2024 | 28315 | 0.100 |
Why?
|
| Endometrial Neoplasms | 1 | 2014 | 108 | 0.100 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 5166 | 0.100 |
Why?
|
| Male | 10 | 2024 | 64425 | 0.080 |
Why?
|
| Combined Modality Therapy | 3 | 2020 | 1212 | 0.080 |
Why?
|
| Cohort Studies | 4 | 2020 | 5047 | 0.080 |
Why?
|
| Female | 12 | 2026 | 70342 | 0.070 |
Why?
|
| Time Factors | 1 | 2019 | 6166 | 0.070 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2020 | 387 | 0.070 |
Why?
|
| Adult | 5 | 2024 | 31035 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 1069 | 0.060 |
Why?
|
| Bias | 1 | 2026 | 149 | 0.060 |
Why?
|
| Observer Variation | 1 | 2026 | 311 | 0.060 |
Why?
|
| Survival Rate | 2 | 2020 | 2105 | 0.050 |
Why?
|
| Adolescent | 5 | 2020 | 20816 | 0.050 |
Why?
|
| Lung | 2 | 2021 | 1532 | 0.050 |
Why?
|
| Steroids | 1 | 2024 | 168 | 0.050 |
Why?
|
| Propensity Score | 1 | 2024 | 271 | 0.050 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2021 | 11 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2024 | 357 | 0.040 |
Why?
|
| Chemoradiotherapy | 1 | 2022 | 124 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2026 | 2076 | 0.040 |
Why?
|
| Incidence | 2 | 2019 | 3329 | 0.040 |
Why?
|
| Perfusion | 1 | 2021 | 209 | 0.040 |
Why?
|
| Michigan | 1 | 2019 | 47 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2020 | 173 | 0.040 |
Why?
|
| Prognosis | 2 | 2019 | 4847 | 0.040 |
Why?
|
| Algorithms | 1 | 2026 | 1663 | 0.040 |
Why?
|
| Radiation Injuries | 1 | 2019 | 141 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 1 | 2019 | 156 | 0.030 |
Why?
|
| Hypopituitarism | 1 | 2017 | 17 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2019 | 356 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2019 | 394 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 1394 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2020 | 3115 | 0.030 |
Why?
|
| Machine Learning | 1 | 2020 | 380 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 1481 | 0.030 |
Why?
|
| Endoscopy | 1 | 2017 | 266 | 0.030 |
Why?
|
| Child | 3 | 2020 | 26194 | 0.030 |
Why?
|
| Reoperation | 1 | 2017 | 813 | 0.030 |
Why?
|
| Young Adult | 2 | 2019 | 10000 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1376 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2891 | 0.020 |
Why?
|
| Vagina | 1 | 2014 | 207 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1320 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2190 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 6764 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2019 | 8622 | 0.010 |
Why?
|
| Infant | 1 | 2019 | 13298 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 15015 | 0.010 |
Why?
|